No Prescription |
 |
 | ||
|
Fluconazole Generic Diflucan |
|
| ||
No Prescription » Prescription Drugs 8 » Fluconazole Generic Diflucan Indications:Fluconazole is indicated for the treatment of the following conditions:1.Mucosal candidiasis. These include oropharyngeal oesophageal non-invasive bronchopulmonary infections candiduria mucocutaneous and chronic oral atrophic candidiasis (denture sore mouth). Normal hosts and patients with compromised immune function may be treated. 2.Vaginal candidiasis acute or recurrent. 3.Prevention of fungal infection in immunocompromised patients considered at risk as a consequence of HIV infections or neutropenia following cytotoxic chemotherapy radiotherapy or bone marrow transplant. 4.Fluconazole 50 mg & 150 mg capsules are also indicated for the treatment of dermatomycoses including tinea pedis tinea corporis tinea cruris pityriasis versicolor & candidiasis. Dosage and Administration:The daily dose of fluconazole should be based on the nature and severity of the fungal infection. Most cases of vaginal candidiasis respond to single dose therapy. Therapy for those types of infections requiring multiple dose treatment should be continued until clinical parameters or laboratory tests indicate that active fungal infection has subsided. An inadequate period of treatment may lead to recurrence of active infection. Patients with AIDS and recurrent oropharyngeal candidiasis usually require maintenance therapy to prevent relapse.AdultsFor oropharyngeal candidiasis the usual dose is 50 mg once daily for 7-14 days. If necessary treatment can be continued for longer periods in patients with severely compromised immune function. For atrophic oral candidiasis associated with dentures the usual dose is 50 mg once daily for 14 days administered concurrently with local antiseptic measures to the denture.For other candidal infections of mucosa (except vaginal candidiasis see below) e.g. oesophagitis candiduria mucocutaneous candidiasis etc. the usual effective dose is 50 mg daily given for 14-30 days.In unusually difficult cases of mucosal candidal infections the dose may be increased to 100 mg daily. For vaginal candidiasis fluconazole 150 mg should be administered as a single oral dose. Median time to onset of symptom relief following a 150 mg single oral dose for the treatment of vaginal candidiasis is one day. The range of time to onset of symptom relief is one hour to nine days. For the prevention of fungal infections in immunocompromised patients the dose should be 50 mg once daily while the patient is at risk as a consequence of receiving cytotoxic chemotherapy radiotherapy or bone marrow transplant. A higher dose of 100 mg/day may be used in patients at risk of severe recurrent infections. For treatment of dermatomycoses the usual dosage is 50 mg once daily or 150 mg once weekly for two to four weeks. Tinea pedis may require treatment for up to six weeks. ChildrenAs with similar infections in adults the duration of treatment is based on the clinical and mycological response. Fluconazole is administered as a single dose each day.The recommended dosage of fluconazole for mucosal candidiasis is 3 mg/kg daily. A loading dose of 6 mg/kg may be used on the first day to achieve steady state levels more rapidly. For the prevention of fungal infections in immunocompromised patients considered at risk as a consequence of neutropenia following cytotoxic chemotherapy or radiotherapy the dose should be 3 - 12 mg/kg daily depending on the extent and duration of the induced neutropenia (see adult dosing). For children with impaired renal function the daily dose should be reduced in accordance with the guidelines given for adults.Children 4 weeks of age and youngerNeonates excrete fluconazole slowly. In the first two weeks of life the same mg/kg dosing as in older children should be used but administered every 72 hours. During weeks 3 and 4 of life the same dose should be given every 48 hours. Buy Fluconazole Generic Diflucan and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Fluconazole Generic Diflucan: Product Type: Prescription Drugs 8 Fluconazole ( Generic Diflucan ) Fluconazole (Generic Diflucan) Generic Diflucan 200mg 50mg 28 Tablets Generic Diflucan Fluconazole
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
